What you should know:
1. The program will support reimbursement coding questions and case management on behalf of patients and providers.
2. Musculoskeletal Clinical Regulatory Advisors will execute the program in conjunction with the spine device company.
3. Clinical trials have shown that lumbar total disc replacement maintains spinal motion, reduces the likelihood of adjacent segment disease and leads to quicker recovery, according to Centinel Spine.
4. Prodisc L received FDA approval for two-level use in the lumbar spine in April.
5. Jack Zigler, MD, of Plano-based Texas Back Institute, implanted the first two-level Prodisc L in 2002.
6. Centinel Spine’s Prodisc portfolio features six devices, including an anterior and anterior-lateral approach to lumbar disc replacement and four cervical disc replacement implants.
More articles on devices:
A simple solution to the health insurance marketplace: Authorize interstate competition
Where orthopedic PE partnerships stand in 2020
Facet joint replacement, stem cells & AR: 9 surgeons discuss new technologies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.